Gland Pharma Ltd (NSE:GLAND) reports a 6% revenue increase, driven by US market performance and strategic product launches.

Fintel reports that on October 27, 2025, D. Boral Capital maintained coverage of UroGen Pharma (NasdaqGM:URGN) with a Buy ...

For the base business (Gland), quarterly revenue increased 1% YoY, with half-yearly revenue up 2%. Quarterly EBITDA for the ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

When everything comes together, pharma and biotech can do a great deal even if some of the data isn’t as strong, as long as ...

As more pharma companies launch DTC platforms, marketers will need to develop strategies that take patient experience and transparency into account.

Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...

On October 29, TD Cowen a‌na​lyst Brendan Smith initiated coverage of West Pharmaceutical Services, Inc. (NYSE:WST) with a Buy rating and a‍ pr‌ice⁠ target of $350, as reported by The Fly.

One of the nation’s most powerful pharmacy intermediaries is quietly charging the military’s health insurance program $484 ...

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock ...

Pharma Hub of India: Hyderabad, the capital of Telangana, is famously known as the Pharma Hub of India. The city is a global center for pharmaceutical manufacturing, biotech innovation, and vaccine ...